Hanmi Pharmaceutical's first glucagon-like peptide-1 (GLP-1)-based obesity treatment "Epeglenatide"

Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.